Live Breaking News & Updates on Psoriatic Arthritis Patients Achieved

Stay updated with breaking news from Psoriatic arthritis patients achieved. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK279 a Highly Selective Oral TYK2 Inhibitor for the Treatment of Active Psoriatic Arthritis

Takeda TSE4502NYSETAK today announced positive topline results from its randomized doubleblind placebocontrolled multipledose Phase 2b trial evaluating TAK279 an investigational oral allosteric tyrosine kinase 2 TYK2 inhibitor with next generation selectivity in people with active psoriatic arthritis. ....

New Orleans , United States , Mark Dole , Jun Saito , Greenwood Carriero , Takeda Pharmaceuticals , Exchange Commission , American College Of Rheumatology , Takeda Pharmaceutical Company Limited , International Media , American Academy Of Dermatology Annual Meeting , Society For Investigative Dermatology Annual Meeting , Topline Results , Significantly Greater Proportion , Psoriatic Arthritis Patients Achieved , Positive Results , Takeda Intends , Full Clinical Results Will , Upcoming Medical , American College , Andy Plump , Fiscal Year , Psoriasis Area , Severity Index , Tyrosine Kinase , Annual Report ,